Module 9 2021

22/03/2021

TOPRA MSc Module 9 - Registration of Biological, Biotechnology and Advanced Therapy Products

Immunogenicity issues

Isabelle Cludts, Scientist

National Institute for Biological Standards and Control (NIBSC) Medicines and Healthcare products Regulatory Agency, UK

TOPRA Module 9 23 rd March 2021

The Organisation for Professionals in Regulatory Affairs

1

Disclaimer

The views and opinions expressed herein represent the experience of the presenter and should not be attributed to any regulatory authority or used in place of guidelines, guidances & regulations.

The Organisation for Professionals in Regulatory Affairs

2

1